Cloning and characterization of hGMEB1, a novel glucocorticoid modulatory element binding protein  by Thériault, Jimmy R et al.
Cloning and characterization of hGMEB1, a novel glucocorticoid
modulatory element binding protein
Jimmy R. The¤riault, Steve J. Charette, Herman Lambert, Jacques Landry*
Centre de recherche en cance¤rologie de l’Universite¤ Laval, L’Ho“tel-Dieu de Que¤bec, 11 co“te du Palais, Quebec, Que. G1R 2J6, Canada
Received 6 April 1999
Abstract A 21-bp element called glucocorticoid modulatory
element (GME) modulates the glucocorticoid receptor-mediated
responses via the binding of an as yet poorly characterized trans-
acting complex of proteins containing the 88-kDa GMEB1 and
the 67-kDa GMEB2. Using heat shock protein 27 (HSP27) as
bait in the yeast two-hybrid assay, we cloned a 1.83-kb cDNA
encoding a novel 573-amino acid protein called human GMEB1
(hGMEB1). hGMEB1 possesses a KDWK domain, contains
sequences almost identical (36/38) to three tryptic peptides of rat
GMEB1 and shares 38% identity with rat GMEB2. hGMEB1 is
ubiquitously expressed as a 85-kDa protein in all cell lines and
tissues examined. In vitro translated hGMEB1 bound specifically
to GME oligonucleotides yielding a complex of similar size to the
complex obtained using rat liver nuclear extracts. Both
complexes were supershifted with an antibody specific to
hGMEB1. Co-immunoprecipitation experiments confirmed the
in vivo interaction of HSP27 with hGMEB1.
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1. Introduction
The tyrosine aminotransferase (TAT) gene possesses a num-
ber of cis-acting elements allowing liver tissue-speci¢c regula-
tion by multiple converging signaling pathways such as those
activated by glucocorticoids, insulin and activators of protein
kinase A and protein kinase C. Glucocorticoid tissue-speci¢c
regulation occurs in part through the cooperative action of a
glucocorticoid response element (GRE) and a binding site for
the liver-speci¢c hepatocyte nuclear factor-3 located in a glu-
cocorticoid-responsive unit at between 32.6 and 32.3 kb of
the start codon [1^3]. In unstimulated cells, the glucocorticoid
receptor is found in the cytoplasm associated with a complex
of heat shock proteins composed of HSP90, HSP70 and p60
[4]. Upon binding to glucocorticoids, the receptor translocates
into the nucleus where it forms DNA-receptor-steroid com-
plexes at the GRE resulting, through interactions with coac-
tivators, in an enhanced transcriptional activity [5,6].
A 26-bp cAMP response element (CRE) together with a
hepatocyte nuclear factor-4 binding site situated 50 bp apart
from each other at 33.6 kb from the start site provides the
liver-speci¢c cAMP-dependent transcriptional activation of
the TAT gene and is the site of inhibition of TAT induction
by phorbol esters (protein kinase C pathway) and insulin [2,7^
11]. TAT-CRE is an asymmetrical and low a⁄nity CRE,
which has low enhancer activity by itself [8]. A 6U concaten-
ated repeat of TAT-CRE or the presence of a hepatocyte
nuclear factor-4 binding site in tandem with a single repeat
of TAT-CRE is required to confer cAMP responsiveness to a
minimal heterologous promoter [2]. However, another activity
has been ascribed to this element. A 21-bp oligonucleotide
overlapping with the CRE and named glucocorticoid modu-
latory element (GME) causes a cell type- and cell density-
dependent left shift in the dose-response curve of sub-saturat-
ing concentrations of glucocorticoids and enhances the gene
response to saturating concentrations of anti-glucocorticoids
(e.g. dexamethasone 21-mesylate) [12^17]. In tandem with a
GRE in a minimal promoter gene, GME does not increase the
maximum response to glucocorticoid but alters the EC50 of
the gene dose-response curve [13,14]. Gel shift assays using
TAT-CRE/GME oligonucleotides identi¢ed three protein
complexes. Two of these complexes are competed by an au-
thentic symmetric CRE and have been shown to contain the
cAMP response element binding protein (CREB) [7,8]. CREB
is a member of the CREB/CREM/ATF-1 family of transcrip-
tional factors that requires phosphorylation mediated pre-
dominantly by protein kinase A for full activity [18]. The
other protein complex is not competed by symmetric CRE.
It corresponds to a multimeric complex of some 550 kDa,
composed of two proteins of 88 and 67 kDa denoted GME
binding protein-1 (GMEB1) and GMEB2, respectively [19].
Rat GMEB2 is unrelated to CREB and belongs to a new
family of KDWK domain-containing nuclear factors [20].
From the partial amino acid sequences of three tryptic frag-
ments, rat GMEB1 also appears to be a new protein unrelated
to CREB [19].
In the present study, we report the isolation of a cDNA
encoding a novel KDWK domain-containing protein 38%
identical to rat GMEB2 and with sequences 95% identical
to the three tryptic peptides of rat GMEB1. In the gel shift
assay, the in vitro translated protein called hGMEB1 dis-
placed radiolabeled TAT-CRE/GME to the same level as
rat liver nuclear extract. In both cases, the complexes were
supershifted by a polyclonal antibody reacting speci¢cally
against hGMEB1. It is thus concluded that hGMEB1 is a
novel trans-acting DNA binding protein that may mediate
the demonstrated functions of GME as a positive modulator
of the glucocorticoid response.
2. Materials and methods
2.1. Cell culture
HeLa, CCL39 and 293 cells were grown in DMEM medium sup-
plemented with 10% fetal bovine serum. CHO cells were grown in K-
MEM medium with 10% fetal bovine serum. NIH 3T3 cells were
grown in DMEM medium supplemented with 10% calf serum. Hu-
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man umbilical vein endothelial cells (HUVEC) were established and
grown as described [21,22].
2.2. Bu¡ers
PBS contained 137 mM NaCl, 5 mM KCl, 10 mM Na2HPO4 and
11 mM glucose, pH 7.2. TNEPT bu¡er was composed of 20 mM Tris-
HCl, pH 7.4, 120 mM NaCl, 1 mM EDTA, 0.1 mM NaVO4, 1 mM
phenylmethylsulfonyl £uoride and 1% Triton X-100. The gel shift
assay bu¡er was made of 10 mM HEPES/KOH pH 7.9, 4% Ficoll
400, 30 mM KCl, 5 mM MgCl2, 4 mM spermidine, 0.1 mM EDTA
pH 8.0, 0.25 mM DTT and 0.25 mM phenylmethylsulfonyl £uoride.
TBS was made of 10 mM Tris-HCl pH 7.4 and 150 mM NaCl.
2.3. Two-hybrid screening
Full-length hamster HSP27 was cloned in phase with LexA in
pBTM116 vector to produce a bait fusion protein [23]. The library
used for screening was a HeLa cDNA library cloned at the EcoRI-
XhoI site of pGAD GH (Clontech). Two-hybrid screening was done
by sequential transformation of bait and library vectors in L40 yeast
[23,24]. After transformation, yeasts were plated on triple-selective
media (lacking histidine, leucine and tryptophan) and incubated at
30‡C until colonies appeared. Colonies that grew more than 2 mm
were tested for L-galactosidase activity using a colony lift ¢lter assay.
The plasmids from positive clones were puri¢ed, co-transfected with
LexA-Ras(V12) to identi¢ed false-positive clones [25] and then probed
by Southern blot with a HSP27 cDNA probe to eliminate HSP27
clones. Among the remaining positive clones, clone 70-1 was picked
as the one yielding the strongest signal and used to identify by South-
ern blot a number of related plasmids including clone 130-5. The
EcoRI-XhoI inserts of clone 130-5 and 70-1 were introduced at the
EcoRI-XhoI site of pGEX-4T-3 to produce plasmids pGEX-4T-3-
hGMEB1 and pGEX-4T-3-hGMEB1/CT, respectively. The plasmids
were used to produce the glutathione S-transferase (GST) fusion pro-
teins GST-hGMEB1 and GST-hGMEB1/CT in the Escherichia coli
protein expression system of Pharmacia (Uppsala, Sweden) according
to the manufacturer’s instructions. The EcoRI-XhoI fragment of clone
130-5 was also inserted at the EcoRI-SalI site of the expression vector
pCMV5 to produce plasmids pCMV5-hGMEB1. pCIneo-myc-
hGMEB1 was constructed in pCIneo (Promega, Madison, WI,
USA) by inserting a double-stranded oligonucleotide corresponding
to the myc epitope in frame with the open reading frame contained in
clone 130-5.
2.4. Immunodetection of GMEB1
The polyclonal antibody EL-71 recognizing hGMEB1 was raised in
rabbit against the fusion protein GST-hGMEB1/CT. Cell and mouse
tissue extracts were prepared in SDS-PAGE sample bu¡er. The pro-
teins were separated by electrophoresis, transferred on nitrocellulose
membranes, and probed with EL-71 diluted 1/1000 in TBS. Antigen-
antibody complexes were revealed with HRP-anti-rabbit IgG antibod-
ies diluted 1/5000 in TBS using the ECL detection kit (Amersham).
2.5. Immuno£uorescence microscopy of hGMEB1
Immuno£uorescence was performed on HeLa cells growing on glass
coverslips. Control cells or cells transfected with pCIneo-myc-
hGMEB1 were ¢xed with 3.7% formaldehyde for 10 min and permea-
bilized with 0.1% Triton X-100 for 1 min at room temperature.
hGMEB1 was detected using the EL-71 antibody diluted 1/50 in
PBS and the hGMEB1 antigen-antibody complexes were revealed
with FITC-labeled anti-rabbit IgG antibodies diluted 1/25 in PBS.
myc-hGMEB1 was detected using the anti-myc antibody 9E10 diluted
1/100 in PBS and the antigen-antibody complexes were revealed with
Texas red-labeled anti-mouse IgG diluted 1/50 in PBS. Confocal mi-
croscopy was performed using a Bio-Rad MRC-1024 imaging system
mounted on a Nikon Diaphot-TDM equipped with a 60U oil objec-
tive lens with a numerical aperture of 1.4.
2.6. Coimmunoprecipitation and GST pull-down assay
Five Wg of the expression vector pCMV5-hGMEB1 and pCIneo-
huHSP27 were transfected alone or in combination in exponentially
growing HeLa or NIH 3T3 cells (4U105 cells in 25-cm2 tissue culture
£asks) by calcium phosphate precipitation. The empty plasmids
pCMV5 or pCIneo were used as ¢lling DNA to bring the ¢nal plas-
mid concentration to 10 Wg DNA per £ask. After 48 h, the cells were
lysed in TNEPT bu¡er, centrifuged at 17 000Ug for 10 min at 4‡C
and processed either for immunoprecipitation or for GST pull-down
assays. For immunoprecipitation, the clari¢ed supernatants were in-
cubated for 45 min at 4‡C in TNEPT bu¡er with anti-human HSP27
(Hu27) absorbed to protein A-Sepharose. GST pull-down was done
similarly except that the extracts were incubated with GST, GST-
hGMEB1 or GST-hGMEB1/CT coupled to glutathione beads. In
both cases, the beads were pelleted and washed four times in TNEPT
bu¡er. The pellets as well as a portion of the total cell extracts were
processed for immunodetection with either anti-hGMEB1 or anti-
HSP27.
2.7. Electrophoretic mobility shift assay
Rat liver nuclear extracts were prepared as reported [26]. Primed
(hGMEB1-producing) and unprimed reticulocyte lysates were pre-
pared using the plasmids pCIneo-myc-hGMEB1 and empty pCIneo,
respectively, in the TNT T7 rabbit reticulocyte lysate expression sys-
tem of Promega (Madison, WI, USA), according to the manufactur-
er’s protocol. A 32P-labeled doubled-stranded GME oligonucleotide
sequence corresponding to the rat TAT sequence at position between
33654 and 33634 bp from the start of transcription was produced by
annealing the oligonucleotides 5P-gatctCTTCTGCGTCAGCGCCAG-
TATg-3P and 3P-aGAAGACGCAGTCGCGGTCATAcctag-5P (low-
er-case letters indicate added nucleotides to produce BglII and BamHI
cohesive ends) and ¢lling the 5P protruding ends with Klenow enzyme
in the presence of [K-32P]dATP (Dupont Canada Inc.) at room tem-
perature. The oligonucleotide was puri¢ed over a 12% polyacrylamide
gel and electroeluted for 45 min at room temperature. 32P end-labeled
GME probes (10.5 fmol, 180 000 cpm) were incubated with adult rat
liver nuclear extract (3 Wg) or reticulocyte lysates (2 or 4 Wl) in a total
volume of 10 Wl for 30 min at room temperature with, in addition,
boiled and autoclaved salmon sperm DNA (0.3 Wg) and 20U single-
stranded unlabeled GME. Competition experiments used the follow-
ing unlabeled and un¢lled double-stranded oligonucleotides (only the
upper strand sequence is given): TAT GME, see above; consensus
GRE, 5P-gatctTGTACAGGATGTTCTg-3P (lower-case letters: Bam-
HI and BglII sites); collagenase AP1, 5P-aattcGTGTCTGACT-
CATGCTTTg-3P (EcoRI sites); and symmetric CRE consensus, 5P-
aattcAAATTGACGTCATGGTAAg-3P (EcoRI sites). In supershift
experiments, the antibodies were added with the protein extracts 30
min at room temperature before addition of the labeled probe. Elec-
trophoresis was carried out in 5% non-denaturing polyacrylamide gel
at 150 V in 0.25UTris-borate-EDTA bu¡er. The dried gels were auto-
radiographed for 8^15 h at room temperature with Kodak X-omat
XAR-5 ¢lm.
3. Results
3.1. Cloning and sequence analysis of hGMEB1
A two-hybrid screen of a plasmid library of fusions between
the activation domain of Gal4 and poly-dT-ampli¢ed cDNA
from HeLa cells was made using full-length Chinese hamster
HSP27 fused to the LexA DNA binding domain as bait.
Among the clones obtained that were con¢rmed to produce
real HSP27 interacting proteins, one clone (clone 70-1) con-
tained a 461-bp sequence encoding a 115-amino acid peptide
(Fig. 1). Southern blot analysis of the other clones using clone
70-1 as a probe identi¢ed 28 clones of a length similar to 70-1
and four longer clones. The longer species, typi¢ed by clone
130-5, were redundant clones of a 1828-bp cDNA containing
an open reading frame of 573 amino acids starting at position
7. Clone 70-1 corresponded to the 3P end of clone 130-5 and
encoded the last 115 amino acids of the protein.
Search for homology with published sequences using the
BLAST program [27] revealed 38% identity between the pep-
tide encoded by clone 130-5 and the 67-kDa rat glucocorticoid
modulatory element binding protein GMEB2 (Fig. 1A). The
search also identi¢ed a region located between residues 92 and
185, having a high degree of similarity with a number of
proteins in a domain called KDWK [28]. Rat GMEB2 and
clone 130-5 peptide are 80% identical in the KDWK domain
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(Fig. 2). Rat GMEB2 binds TAT-CRE/GME as a multimeric
complex with an 88-kDa protein called rat GMEB1 [20]. Rat
GMEB1 has been puri¢ed to homogeneity and the sequences
of three tryptic peptides have been determined [19]. Two of
these peptides were found integrally in clone 130-5; 16 of the
18 residues of the third peptide are conserved (overlined se-
quences in Fig. 1). This important similarity of sequence with
rat GMEB2 and particularly with the tryptic fragments of rat
GMEB1 suggested that the protein encoded by clone 130-5
was a human GMEB and probably the human GMEB1. For
these reasons, the protein was named hGMEB1. Other fea-
tures of hGMEB1 sequences are summarized in Fig. 1B and
described in Section 4. The nucleotide and deduced amino
acid sequences of hGMEB1 have been deposited in the Gen-
Bank database under GenBank accession number AF099013.
3.2. hGMEB1 is a ubiquitously expressed nuclear protein
An antibody against hGMEB1 (EL-71) was prepared in
rabbit using a recombinant fusion protein made of GST and
the last 115 amino acids of hGMEB1 (hGMEB1/CT). In
Western blot using EL-71, a polypeptide of some 85 kDa
was recognized in a number of cell lines from human
(HeLa, 293 and HUVEC), Chinese hamster (CCL39, CHO)
and mouse (NIH 3T3), in rat liver and di¡erent mouse tissue
extracts (Fig. 3A). The apparent molecular weight of the EL-
71-reacting polypeptides contrasted with the predicted molec-
ular weight of 62.5 kDa calculated from the protein sequence
of hGMEB1 and might re£ect the high content of acidic res-
idues in hGMEB1. A band with identical mobility was
strongly expressed in extracts from HeLa cells that were trans-
fected with pCMV5-hGMEB1. This result and the fact that
the N-terminus sequences of hGMEB1 and rat GMEB2 were
highly conserved (Fig. 1A) suggested that clone 130-5 con-
tained the entire coding sequence of hGMEB1. The EL-71
antibody also detected a smaller product migrating at
43 kDa. The 43-kDa species was particularly strong in tissue
Fig. 1. A: Amino acid sequence comparison of hGMEB1 with rat GMEB2. Alignment of deduced amino acid sequences of clone 130-5
(hGMEB1) with rat GMEB2 (rGMEB2 [20], GenBank accession number AF059273). Black and gray backgrounds indicate identity and similar-
ity, respectively. Overlined sequences identify three partially sequenced tryptic fragments of rat GMEB1 [19]. The nucleotide and deduced ami-
no acid sequences of hGMEB1 have been deposited in the GenBank database under GenBank accession number AF099013. B: Schematic rep-
resentation of the protein encoded by hGMEB1 clone 130-5, clone 70-1 and rat GMEB2. Hatched boxes refer to the conserved KDWK
domain. S/T and Q indicate serine/threonine-rich and glutamine-rich regions, respectively. K indicates putative K-helix coiled-coil domains as
predicted by MacStripe [48].
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extracts suggesting that it could be a degradation product of
hGMEB1.
The intracellular localization of hGMEB1 was determined
by immuno£uorescence in control HeLa cells and in HeLa
cells transfected with pCIneo-myc-hGMEB1. Both the endog-
enous hGMEB1 detected with the EL-71 antibody and the
transfected myc-tagged proteins detected by either the EL-71
or the 9E10 antibodies showed a strong nuclear localization
(Fig. 3B).
3.3. hGMEB1 interacts with the GME oligonucleotide
To con¢rm that hGMEB1 was a GMEB protein, myc-
tagged hGMEB1 (myc-hGMEB1) was translated in a reticu-
locyte lysate and tested in gel shift assay using 32P-labeled
GME. In contrast to unprogrammed reticulocyte lysates
(empty vector) which yielded no complex formation, lysates
programmed with myc-hGMEB1 cDNA produced a discrete
gel-shifted band (Fig. 4A, lanes 1 and 2). The band was fur-
ther retarded by 9E10 anti-myc, EL-71 anti-hGMEB1 but not
by 12ca5 anti-hemagglutinin (an irrelevant antibody) or pre-
immune serum (Fig. 4A, lanes 9^12). The complex was spe-
ci¢c, being competed by excess cold GME but not by GRE,
CRE or AP-1 oligonucleotides (Fig. 4A, lanes 3^8 and Fig.
4B, lanes 3^5). Rat liver nuclear extracts produced a more
complex pattern of gel-shifted complexes (Fig. 4C), in agree-
ment with previous studies indicating that CREB in addition
to GMEB can bind GME [7,8]. All complexes were competed
by unlabeled GME; however, only the slowest migrating
Fig. 2. Alignment of the KDWK domain of hGMEB1 and other proteins. Alignment of KDWK domain of di¡erent proteins: human
GMEB1, rat GMEB2 (GenBank accession number AF059273), human Sp140 protein (GenBank accession number U63420), human phospho-
protein 75 (Phosphoprt75, GenBank accession number L22343), human NUDR (GenBank accession number AF049459), Drosophila DEAF1
(GenBank accession number AF025458) and open reading frame from C. elegans (GenBank accession number Z49067). Amino acids identical
or similar in four or more proteins are printed over a dark or gray background, respectively.
C
Fig. 3. Expression and intracellular localization of GMEB1 protein.
A: Cell extracts were prepared from Chinese hamster CCL39 and
CHO (80 Wg), mouse NIH 3T3 (80 Wg), human HeLa and 293
(80 Wg), HUVEC (40 Wg), HeLa cells transfected with pCMV5-
hGMEB1 (hGMEB1, 9 Wg) or from various mouse tissues as indi-
cated (40 Wg). The proteins were separated by SDS-PAGE and
transferred on a nitrocellulose membrane for Western analysis. The
arrows indicate the position of hGMEB1 as detected using EL-71.
Numbers on the left indicate the position of molecular weight
markers. B: Control HeLa cells (a) or HeLa cells transfected with
pCIneo-myc-hGMEB1 (b and c) were ¢xed and processed for im-
muno£uorescence microscopy using anti-hGMEB1 EL-71 antibody
(a and b) or anti-myc 9E10 antibody (c). b and c are from the same
¢eld using FITC and Texas red-labeled anti-rabbit and anti-mouse
secondary antibodies respectively. Note that endogenous hGMEB1
is barely visible in b due to the use of a lower intensity scale.
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band, which migrated at a rate comparable to the complex
formed with myc-hGMEB1 produced in reticulocyte lysates,
was supershifted by EL-71 (Fig. 4C, lane 5).
3.4. Interaction of hGMEB1 and HSP27
Further analyses of the interaction of HSP27 with
hGMEB1 in yeast con¢rmed that HSP27 interacted with
both hGMEB1 and hGMEB1/CT, albeit six times more L-
galactosidase activities were generated with hGMEB1 as com-
pared to hGMEB1/CT (data not shown). To determine
whether hGMEB1 interacts with HSP27 in mammalian cells,
NIH 3T3 cells were cotransfected with pCIneo-huHSP27 and
pCMV5-hGMEB1, or transfected with pCMV5-hGMEB1
alone. hGMEB1 was co-immunoprecipitated with HSP27 by
anti-human HSP27 in cells expressing both proteins but not in
cells expressing only hGMEB1 (Fig. 5A). Moreover, endoge-
nous HSP27 present in extracts of CHO and HeLa cells
bound to immobilized GST-hGMEB1 but not to GST-
hGMEB1/CT or GST alone. Immobilized GST-hGMEB1,
but not immobilized GST-hGMEB1/CT or GST alone, also
pulled down myc-tagged hGMEB1 in extracts of pCIneo-myc-
hGMEB1-transfected HeLa cells (Fig. 5B).
4. Discussion
The expression of the TAT gene has been extensively
studied as a paradigm to understand the complex tissue-spe-
ci¢c regulation of gene expression by multiple converging sig-
naling pathways. Among others, two overlapping elements
called TAT-GME and TAT-CRE of 21 and 26 bp, respec-
tively, have been well characterized as important cis-acting
enhancer modules [7,14]. TAT-CRE/GME contains an asym-
metric CRE that was shown in vitro to bind CREB in a
protein kinase A-mediated phosphorylation-dependent man-
ner [8]. Together with a nearby hepatocyte nuclear factor-4
binding element, TAT-CRE/GME is su⁄cient in the liver en-
vironment to reproduce stimulation of TAT gene transcrip-
tion by cAMP inducers such as glucagon [2]. TAT-CRE/GME
is also known to increase the transcriptional activity mediated
by the glucocorticoid receptor [12,14]. This activity is inde-
pendent of CREB binding and instead depends on GMEB1
and GMEB2, two proteins that bind TAT-GME/CRE as a
heteromeric complex of some 550 kDa [19]. A major role
attributed to GME is to modulate glucocorticoid induction
of target genes as a function of cell type and density. This
characteristic of glucocorticoid-regulated genes, which has
been characterized in detail for TAT, was reproduced with a
minimal gene containing only a GME, a GRE and a minimal
promoter, and shown to be dependent on the presence of
GME [12,14^17]. Rat GMEB2 has been cloned recently [20],
however, only partial tryptic peptide sequences have been ob-
tained for rat GMEB1 [19]. In this paper, we reported the
cloning and the characterization of a new protein binding to
GME. The protein was designated hGMEB1 because it is the
¢rst reported human protein with a GME binding activity not
competed by authentic CRE, it has the same apparent molec-
ular weight and possesses identical sequences to tryptic frag-
ments of rat GMEB1 [19], and it is closely related in sequence
to rat GMEB2 [20].
hGMEB1 and GMEB2 possess little homology with other
known nuclear proteins and probably belong to a new protein
family of DNA binding proteins. The only signi¢cant homol-
ogy with other proteins in the databases was found in an 80^
90-amino acid domain described previously as the KDWK
domain [28]. In this domain, hGMEB1 is 80% identical to
rat GMEB2 and ca. 30% identical to a number of other nu-
Fig. 4. Binding of hGMEB1 to GME oligonucleotide in gel shift as-
say. Protein-DNA complexes were separated by non-denaturing elec-
trophoresis after incubating a 32P-labeled GME oligo with 2 Wl (B)
or 4 Wl (A) of unprogrammed (3) or myc-hGMEB1 programmed
(+) reticulocyte lysates, or 3 Wg of adult rat liver extract (ARL;
lane 13 in A, and lanes 1^5 in C). Binding was competed with the
indicated (100, 200 or 500U) molar excess concentrations of unla-
beled GME, GRE, CRE or AP-1 oligos. Supershift assays were per-
formed using a preimmune serum (pre-Imm), anti-hGMEB1 (EL-
71), anti-myc (9E10) and anti-hemagglutinin (12ca5). The ¢lled ar-
rows indicate the GME/GMEB1 complex. The open arrows indicate
the position the antibody-shift complexes. In D, Western blot of
hGMEB1 in unprogrammed (3), programmed lysate (+) (10 Wl
each) and ARL (15 Wg) using anti-hGMEB1 (EL-71).
Fig. 5. hGMEB1 and HSP27 interact with each other in mammalian
cells. A: Co-immunoprecipitation. NIH 3T3 cells transfected with
pCMV5-hGMEB1 (lane 1) or with pCMV5-hGMEB1 and pCI-
neoHSP27. Total extracts were analyzed by Western blot (Western)
for expression of hGMEB1 and HSP27, or immunoprecipitated with
anti-HSP27 (HU27-IP) and tested for hGMEB1 co-immunoprecipi-
tation. B: GST pull-down assay. Extracts from CHO cells, HeLa
cells or pCIneo-myc-hGMEB1 transfected HeLa cells were incu-
bated with immobilized GST, GST-hGMEB1 or GST-hGMEB1/CT.
Bound proteins were analyzed by Western blot for the presence of
HSP27 and myc-hGMEB1 using Hu27 and 9E10 antibodies, respec-
tively. A fraction of the extracts (5% for HSP27, 10% for myc-
hGMEB1) was also analyzed directly by Western blot to determine
the amount of total HSP27 or myc-hGMEB1 in the cell extracts
(Extract).
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clear proteins from human, rat, Drosophila and Caenorhabdi-
tis elegans (Fig. 2). The role played by the KDWK domain is
unknown. The best characterized of the KDWK domain-con-
taining proteins are Drosophila DEAF-1 and its likely mam-
malian orthologue, NUDR. DEAF-1 is a DNA binding pro-
tein that is thought to be a cofactor contributing to the
autoregulation of the Drosophila Deformed gene [28].
NUDR has been isolated for its capacity to bind to a syn-
thetic retinoic acid response element and is thought to be a
cofactor that regulates transcription during the di¡erentiation
of testicular cells [29]. Other proteins with a homologous
KDWK domain include mammalian Suppressin [30], a pro-
tein highly identical to NUDR, the nuclear body proteins
SP140, LYSP100 and SP100 [31^33], two interferon-induced
nuclear phosphoproteins of unknown function [34], and sev-
eral uncharacterized C. elegans gene products [35]. hGMEB1
lacks a zinc ¢nger domain and a leucine zipper motif and has
no LXXLL motifs which mediate interactions of nuclear re-
ceptor coactivators with receptors [36]. Of possible signi¢-
cance is the existence of two glutamine-rich (24%) regions
located in the central portion of hGMEB1. Glutamine-rich
regions are found in several nuclear proteins and coactivators,
and are likely to be involved in protein-protein interactions
regulating transcriptional activation. For example, short glu-
tamine-rich regions mediate the interaction of CREB with
components of the TFIID complex [37,38]. The glutamine-
rich regions of TAFII130 are also required for binding to
Sp1A, Sp1B and CREB, and for Sp1-mediated transcriptional
enhancement [39]. hGMEB1 also possesses two serine/threo-
nine-rich domains and also two putative K-helix coiled-coil
domains, one of which extends over a glutamine-rich region
(see Fig. 1B).
In rat, GMEB1 and GMEB2 have been shown to interact
with each other and to bind the GME as a heteromultimeric
complex of some 550 kDa. We have shown that this complex,
which is shifted by the anti-hGMB1 antibody in the rat liver
extract, is of the same size as the complex formed with in vitro
translated hGMEB1, arguing that hGMEB1 can also multi-
merize with itself. This is further supported by the ¢nding that
hGMEB1 can be pulled down by immobilized GST-hGMEB1
(Fig. 5) and interacts with itself in the two-hybrid system
(data not shown).
The signi¢cance of the interaction of HSP27 with hGMEB1
remains to be demonstrated. There is a well-documented role
of heat shock proteins in the cell response to steroids. The
glucocorticoid receptor is maintained in a high-a⁄nity ligand
binding conformation by associating with a heterocomplex
formed of HSP90, HSP70 and other proteins. This association
is essential to maintain a ligand binding conformation and
may also be involved in the translocation of the activated
receptor to the nucleus (for review see [4]). HSP27 belongs
to the small heat shock protein family, a group of phyloge-
netically conserved proteins that includes KA- and KB-crystal-
lin [40]. Intriguingly, proteins of this family are also under
steroid regulation. Human HSP27 has been described in sev-
eral reports as a p24 estrogen-induced protein and is overex-
pressed in several estrogen receptor-positive tumors [41^43].
KB-crystallin accumulates in NIH 3T3 cells in response to
dexamethasone [44], and Drosophila HSP27 is induced by
the steroid hormone ecdysone [45]. Several characteristics
make HSP27 a good candidate as a modulator of the cell
type- and cell density-modulatory properties reported for
GME. HSP27 is expressed at highly variable levels in di¡erent
cell lines [40] and it shows variation in its intracellular local-
ization as a function of cell con£uence [46]. Furthermore,
HSP27 was ¢rst cloned in mouse as a cell growth-regulated
protein [47]. A number of genes have been shown to undergo
a left shift in dose-response curves induced by glucocorticoids
or to be induced di¡erentially as a function of con£uence [16].
Our ¢nding that hGMEB1, like HSP27, is a ubiquitously ex-
pressed protein suggests that its function is not restricted to
the TAT gene or to the liver.
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